0001579428-13-000004.txt : 20131030 0001579428-13-000004.hdr.sgml : 20131030 20131029174944 ACCESSION NUMBER: 0001579428-13-000004 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20131030 DATE AS OF CHANGE: 20131029 EFFECTIVENESS DATE: 20131030 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Axsome Therapeutics, Inc. CENTRAL INDEX KEY: 0001579428 IRS NUMBER: 454241907 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-199018 FILM NUMBER: 131177327 BUSINESS ADDRESS: STREET 1: 45 ROCKEFELLER PLAZA, SUITE 2000 CITY: NEW YORK STATE: NY ZIP: 10111 BUSINESS PHONE: 212-203-5072 MAIL ADDRESS: STREET 1: 45 ROCKEFELLER PLAZA, SUITE 2000 CITY: NEW YORK STATE: NY ZIP: 10111 D/A 1 primary_doc.xml X0707 D/A LIVE 0001579428 Axsome Therapeutics, Inc. 45 ROCKEFELLER PLAZA, SUITE 2000 NEW YORK NY NEW YORK 10111 212-203-5072 DELAWARE None None Corporation true 2012 Herriot Tabuteau 45 Rockefeller Plaza, Suite 2000 New York NY NEW YORK 10111 Executive Officer Director Pharmaceuticals Decline to Disclose 06b true 0001579428-13-000003 2013-06-28 false true true false 0 Brookline Group, LLC 153587 None None 2501 Twentieth Place South Suite 275 Birmingham AL ALABAMA 35223 SC SOUTH CAROLINA IL ILLINOIS NY NEW YORK CT CONNECTICUT GA GEORGIA TN TENNESSEE WI WISCONSIN AZ ARIZONA CA CALIFORNIA MO MISSOURI KS KANSAS MS MISSISSIPPI NJ NEW JERSEY TX TEXAS AL ALABAMA CO COLORADO PA PENNSYLVANIA NC NORTH CAROLINA MD MARYLAND MA MASSACHUSETTS true 4000000 3679000 321000 false 41 320000 true 0 Commissions are based on a percentage. This is the maximum cash amount payable assuming full amount of offering is sold. The placement agent will also receive warrants in addition to cash payment. 0 false Axsome Therapeutics, Inc. Herriot Tabuteau Herriot Tabuteau Chief Executive Officer 2013-10-29